Treace Medical Concepts, Inc. TMCI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 205.31M | 207.32M | 212.69M | 218.88M | 213.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 205.31M | 207.32M | 212.69M | 218.88M | 213.75M |
| Cost of Revenue | 42.19M | 42.05M | 42.94M | 44.05M | 42.50M |
| Gross Profit | 163.12M | 165.27M | 169.75M | 174.83M | 171.25M |
| SG&A Expenses | 197.62M | 200.66M | 202.62M | 201.31M | 197.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 258.03M | 262.06M | 265.84M | 266.32M | 261.65M |
| Operating Income | -52.72M | -54.74M | -53.15M | -47.44M | -47.89M |
| Income Before Tax | -59.52M | -61.04M | -59.00M | -50.11M | -49.18M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -59.52 | -61.04 | -59.00 | -50.11 | -49.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -59.52M | -61.04M | -59.00M | -50.11M | -49.18M |
| EBIT | -52.72M | -54.74M | -53.15M | -47.44M | -47.89M |
| EBITDA | -45.35M | -46.68M | -43.53M | -38.38M | -39.46M |
| EPS Basic | -0.93 | -0.96 | -0.93 | -0.79 | -0.79 |
| Normalized Basic EPS | -0.54 | -0.56 | -0.55 | -0.49 | -0.49 |
| EPS Diluted | -0.93 | -0.96 | -0.93 | -0.80 | -0.79 |
| Normalized Diluted EPS | -0.54 | -0.56 | -0.55 | -0.49 | -0.49 |
| Average Basic Shares Outstanding | 257.02M | 254.98M | 253.04M | 251.52M | 250.24M |
| Average Diluted Shares Outstanding | 257.02M | 254.98M | 253.04M | 251.52M | 250.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |